Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetylcysteine and IPPI for Prevention of First Psychotic Episode
NCT03149107Phase 3Terminated
- Sponsor
- University Hospital Bonn
- Start
- Sep 2016
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in schizophrenia, sponsored by University Hospital Bonn. Started Sep 2016; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03149107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03149107.